BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12777081)

  • 1. Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study.
    Warnick RE; Longmore LM; Paul CA; Bode LA
    J Neurooncol; 2003 May; 62(3):289-96. PubMed ID: 12777081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy.
    Kulkarni AV; Guha A; Lozano A; Bernstein M
    J Neurosurg; 1998 Jul; 89(1):31-5. PubMed ID: 9647169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy.
    Field M; Witham TF; Flickinger JC; Kondziolka D; Lunsford LD
    J Neurosurg; 2001 Apr; 94(4):545-51. PubMed ID: 11302651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging.
    Bernays RL; Kollias SS; Khan N; Brandner S; Meier S; Yonekawa Y
    J Neurosurg; 2002 Aug; 97(2):354-62. PubMed ID: 12186464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic consequences of early discharge of patients following supratentorial stereotactic brain biopsy.
    Kaakaji W; Barnett GH; Bernhard D; Warbel A; Valaitis K; Stamp S
    J Neurosurg; 2001 Jun; 94(6):892-8. PubMed ID: 11409516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative bleeding in stereotactic biopsies and its implication on postoperative management: can we predict CT findings?
    Eibach S; Weise L; Setzer M; Seifert V; Senft C
    Stereotact Funct Neurosurg; 2014; 92(2):80-5. PubMed ID: 24481033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions.
    Bernstein M; Parrent AG
    J Neurosurg; 1994 Aug; 81(2):165-8. PubMed ID: 8027795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety assessment of intraparenchymal central nervous system biopsies: Single institution healthcare value review.
    Mazur-Hart DJ; Yaghi NK; Goh JL; Lin Y; Han S
    J Clin Neurosci; 2021 May; 87():112-115. PubMed ID: 33863517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician utilization of a portable computed tomography scanner in the intensive care unit.
    McCunn M; Mirvis S; Reynolds N; Cottingham C
    Crit Care Med; 2000 Dec; 28(12):3808-13. PubMed ID: 11153618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Brain Biopsy Hemorrhage Risk Factors and Implications for Postoperative Care at a Single Institution: An Argument For Postoperative Imaging.
    Barkley AS; Sullivan LT; Gibson AW; Camacho D; Barber JK; Ko AL; Silbergeld DL; Ravanpay AC
    World Neurosurg; 2020 Dec; 144():e807-e812. PubMed ID: 32956884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 126 Consecutive Stereotactic Procedures: Brain Biopsy, Diagnostic Yield, Accuracy, Non-Diagnostic Results, Complications and Follow-up.
    Hakan T; Aker FV
    Turk Neurosurg; 2016; 26(6):890-899. PubMed ID: 27509450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance.
    Shakal AA; Mokbel EA
    J Neurol Surg A Cent Eur Neurosurg; 2014 May; 75(3):177-82. PubMed ID: 23526202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity, timeline, and management of complications after stereotactic brain biopsy.
    Riche M; Marijon P; Amelot A; Bielle F; Mokhtari K; Chambrun MP; Joncour AL; Idbaih A; Touat M; Do CH; Deme M; Pasqualotto R; Jacquens A; Degos V; Shotar E; Chougar L; Carpentier A; Mathon B
    J Neurosurg; 2022 Mar; 136(3):867-876. PubMed ID: 34507289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system.
    Yamada K; Goto S; Kochi M; Ushio Y
    J Clin Neurosci; 2004 Apr; 11(3):263-7. PubMed ID: 14975414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial biopsy and early re-resection practices in the treatment of glioblastoma among AANS/CNS tumor section surgeons.
    Baron RB; Kessler RA; Hadjipanayis CG
    J Neurooncol; 2019 Sep; 144(3):529-534. PubMed ID: 31368054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure.
    Kongkham PN; Knifed E; Tamber MS; Bernstein M
    Can J Neurol Sci; 2008 Mar; 35(1):79-84. PubMed ID: 18380282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment.
    Kim JE; Kim DG; Paek SH; Jung HW
    Acta Neurochir (Wien); 2003 Jul; 145(7):547-54; discussion 554-5. PubMed ID: 12910397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic biopsy in the era of advanced neuroimaging. Does the minimal therapeutic gain justify its current wide use?
    Stranjalis G; Protopapa D; Sakas DE; Chondros D
    Minim Invasive Neurosurg; 2003 Apr; 46(2):90-3. PubMed ID: 12761679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine Postoperative Computed Tomography Is Not Helpful After Elective Craniotomy.
    Freyschlag CF; Gruber R; Bauer M; Grams AE; Thomé C
    World Neurosurg; 2019 Feb; 122():e1426-e1431. PubMed ID: 30465965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted brain biopsy: a comparison of freehand computed tomography-guided and stereotactic techniques.
    Wen DY; Hall WA; Miller DA; Seljeskog EL; Maxwell RE
    Neurosurgery; 1993 Mar; 32(3):407-12; discussion 412-3. PubMed ID: 8455766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.